Strensiq and Pulmicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strensiq (asfotase alfa) and Pulmicort (budesonide). Common drug interactions include respiratory arrest among females and hypercalcaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Strensiq and Pulmicort. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Strensiq?

Strensiq has active ingredients of asfotase alfa. eHealthMe is studying from 7,141 Strensiq users. Check the latest studies of Strensiq.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

On Jul, 15, 2026

22 people who take Strensiq and Pulmicort together, and have interactions are studied.

Strensiq and Pulmicort drug interactions.

What are the common drug interactions of Strensiq and Pulmicort, by gender? *:

female:

Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Urinary tract infection fungal
Viral myocarditis (inflammation of heart muscle caused by viral infection)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Influenza
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
Influenza a virus test positive
Drug ineffective
Neonatal respiratory distress syndrome (a serious medical condition where a newborn baby's lungs cannot provide their body with enough oxygen)
Respiratory failure (inadequate gas exchange by the respiratory system)

male:

Hypercalcaemia (elevated calcium (ca+) level in the blood)
Craniosynostosis (a baby is born with an abnormally shaped skull or develops one during growth)
Respiratory failure (inadequate gas exchange by the respiratory system)
Ocular hypertension (intraocular pressure higher than normal)

What are the common drug interactions of Strensiq and Pulmicort, by age (0-1 to 60+)? *:

0-1:

Hypercalcaemia (elevated calcium (ca+) level in the blood)
Respiratory failure (inadequate gas exchange by the respiratory system)
Craniosynostosis (a baby is born with an abnormally shaped skull or develops one during growth)
Drug ineffective
Neonatal respiratory distress syndrome (a serious medical condition where a newborn baby's lungs cannot provide their body with enough oxygen)
Vomiting
Device related infection
Diarrhoea
Iron deficiency anaemia
Lung disorder (lung disease)

2-9:

Viral myocarditis (inflammation of heart muscle caused by viral infection)
Influenza
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
Influenza a virus test positive
Ocular hypertension (intraocular pressure higher than normal)
Bone density decreased
Humerus fracture (injury to the upper arm bone)
Muscular weakness (muscle weakness)
Acute respiratory failure

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Chills (felling of cold)
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

Hypophosphatasia (metabolic bone disease): 21 people, 95.45%
Vitamin B6 Deficiency: 5 people, 22.73%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 22.73%

* Approximation only. Some reports may have incomplete information.

Do you take Strensiq and Pulmicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously